Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma
Title:
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma
Author:
Moy, Ryan H. Greally, Megan Chou, Joanne F. Li, Jia Desai, Avni M. Chalasani, Sree B. Won, Elizabeth Kelsen, David P. Ilson, David H. Janjigian, Yelena Y. Capanu, Marinela Ku, Geoffrey Y.